Table 1. The characteristics of 34 small pulmonary nodules in 31 patients.
| Patient No. | Gender | Age | Diameter (mm) | Distance to Pleural (mm) | Imaging characteristic | Image Diagnosis | Localization Time (min) | Pathological Result |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 45 | 5 | 22 | solid nodule | malignant | 13 | metastatic endometrial cancer |
| 2 | F | 55 | 6 | 24 | solid nodule | indeterminate | 8 | focal necrosis with calcification |
| 3 | F | 59 | 10 | 32 | GGN | malignant | 7 | carcinoma in situ |
| 4 | F | 58 | 10 | 19 | GGN | indeterminate | 7 | inflammatory changes |
| 5 | M | 69 | 9 | 46 | solid nodule | indeterminate | 6 | moderately to poorly differentiated adenocarcinoma |
| 6 | F | 40 | 3 | 9 | solid nodule | indeterminate | 8 | atypical adenocarcinoma |
| 5 | 14 | solid nodule | 7 | atypical adenocarcinoma | ||||
| 7 | M | 62 | 8 | 39 | GGN | malignant | 23 | metastatic lung adenocarcinoma |
| 8 | M | 60 | 18 | 43 | solid nodule | malignant | 5 | tuberculosis |
| 9 | M | 58 | 8 | 5 | solid nodule | malignant | 7 | metastatic lung adenocarcinoma |
| 10 | F | 39 | 10 | 5 | solid nodule | malignant | 5 | moderately differentiated adenocarcinoma |
| 11 | M | 53 | 7 | 16 | solid nodule | indeterminate | 9 | alveolar epithelial cell hyperplasia |
| 12 | F | 28 | 9 | 12 | solid nodule | indeterminate | 9 | carcinoma in situ |
| 13 | F | 37 | 10 | 35 | solid nodule | benign | 5 | tuberculosis |
| 14 | M | 48 | 6 | 16 | solid nodule | malignant | 7 | metastatic colon cancer |
| 15 | F | 53 | 8 | 51 | solid nodule | indeterminate | 10 | inflammatory changes |
| 16 | F | 63 | 9 | 22 | solid nodule | malignant | 8 | moderately differentiated adenocarcinoma |
| 17 | M | 50 | 12 | 21 | solid nodule | malignant | 11 | well to moderately differentiated adenocarcinoma |
| 6 | 20 | solid nodule | malignant | 11 | inflammatory changes | |||
| 18 | F | 59 | 13 | 19 | solid nodule | malignant | 10 | moderately differentiated adenocarcinoma |
| 19 | F | 47 | 8 | 8 | solid nodule | benign | 3 | lymph node |
| 20 | F | 47 | 3 | 7 | solid nodule | indeterminate | 6 | carcinoma in situ |
| 21 | F | 54 | 8 | 34 | solid nodule | malignant | 13 | metastatic colon cancer |
| 22 | F | 65 | 17 | 9 | solid nodule | malignant | 13 | moderately differentiated adenocarcinoma |
| 23 | F | 37 | 6 | 18 | solid nodule | benign | 5 | carcinoma in situ |
| 24 | F | 65 | 9 | 20 | solid nodule | malignant | 12 | inflammatory changes |
| 25 | F | 51 | 16 | 13 | GGN | malignant | 14 | moderately differentiated adenocarcinoma |
| 26 | M | 51 | 9 | 39 | GGN | indeterminate | 7 | well-differentiated adenocarcinoma |
| 3 | 13 | solid nodule | indeterminate | 10 | inflammatory changes | |||
| 27 | M | 78 | 13 | 29 | solid nodule | malignant | 6 | well-differentiated mucinous carcinoma |
| 28 | F | 45 | 9 | 18 | GGN | indeterminate | 9 | carcinoma in situ |
| 29 | M | 34 | 6 | 14 | solid nodule | benign | 9 | metastatic thyroid papillary carcinoma |
| 30 | F | 58 | 7 | 6 | GGN | benign | 14 | carcinoma in situ |
| 31 | M | 59 | 15 | 29 | solid nodule | malignant | 10 | moderately to poorly differentiated adenocarcinoma |
| Mean ± SD | - | 52.5 ± 11.1 | 8.9 ± 3.8 | 21.4 ± 12.4 | - | - | 9.0 ± 3.8 | - |
GGN: ground-glass nodule.
F: female.
M: male.
SD: standard deviation.